Cure8 trial brief
People with an ileal pouch after UC/IBDU often struggle with fecal incontinence and reduced quality of life. This trial is testing a noninvasive device (Emsella chair) aimed at improving incontinence and patient-reported outcomes.
Adults with J-pouch (IPAA) and fecal incontinence, post-surgery patients, clinicians managing pouch dysfunction, researchers of pelvic-floor or noninvasive neuromodulation therapies.
This is a small, single-site trial (planned enrollment 20) at Cedars-Sinai enrolling adults at least one year after J-pouch surgery who have fecal incontinence. Participants will sit on the device twice weekly for three weeks (28 minutes per session). The study will measure patient-reported quality of life (PROMIS-10) at baseline, 1 month, and 3 months.
The trial excludes patients with active pouchitis, fistula, reclassified Crohn's disease after surgery, implanted metal devices, pregnancy, and those who had a pouch for indications other than UC/IBDU. Results are not reported here; this is a trial record describing the planned study.
This is a small (n=20), single-center study describing the intervention and outcome measures; the record does not report results. Because it's an interventional trial, safety and effectiveness are not established here.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review links specific therapies and surgical options to outcomes that matter to people with IBD — mucosal healing, lower hospitalizations, and reduced need for surgery — and highlights that combining medical and...
Surgical approach to creating an IPAA (j-pouch) affects timing and number of operations and recovery; trends toward more staged procedures may reflect increasing disease severity and preoperative treatment patterns that...
The episode clarifies key differences between Crohn’s and ulcerative colitis, outlines common symptoms that should prompt medical evaluation, and reviews monitoring and complication risks that affect long‑term care.
